跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RISEDRONATO COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RISEDRONATO COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
RISEDRONATO COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Combix S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 30, 2022
Approval ID
9d027de7551768d5
Company
Laboratorios Combix S.L.U.
Type
Standard
Approval Details
Approval Id
9d027de7551768d5
Drug Cima Aemps Name
RISEDRONATO COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
87534
Holder Company Name
Laboratorios Combix S.L.U.
Marketing Company Name
Laboratorios Combix S.L.U.
Authorization Date
2022-05-30
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Combix S.L.U.
Active Ingredients
RISEDRONATO SODIO HEMIPENTAHIDRATO
86,069 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 30, 2022
Approval ID
9d027de7551768d5
Type
Standard
Back to CIMA-AEMPS Approvals